Skip to main content
. Author manuscript; available in PMC: 2015 Jan 1.
Published in final edited form as: Genet Med. 2013 Dec 19;16(7):529–534. doi: 10.1038/gim.2013.187

Table 2.

Case/control study number consists of 50% cancer cases and 50% cancer free controls. Assuming cumulative incidence of colon cancer of 0.03 for individuals in study, α= 0.1, β = 0.2, MAF = minor allele frequency

Subjects necessary to characterize as pathogenic
RR Tumor Type MAF = 0.001 MAF = 0.0001 MAF = 0.00001
RR = 20 Colon 368 3,606 35,988
RR = 10 Colon 830 8,204 81,944
RR = 5 Colon 2,178 21,632 216,170
RR = 2.5 Colon 8,331 82,959 829,236